NM_058216.3:c.135G>T
Variant summary
The NM_058216.3(RAD51C):c.135G>T (p.Glu45Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene RAD51C is a tumor suppressor gene (CancerMine: 5 TSG, 2 oncogene, 1 driver citations). The gene RAD51C is a known oncogene (CancerMine: 5 TSG, 2 oncogene, 1 driver citations). The gene RAD51C is a cancer driver gene (CancerMine: 5 TSG, 2 oncogene, 1 driver citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.E45A: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 492362); p.E45D: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 246164); p.E45= (synonymous): Benign/Likely_benign (ClinVar VariationId 480513, 2 stars); p.E45G: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 140940); p.E45K: Uncertain_significance (ClinVar VariationId 538777, 2 stars); p.E45K: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 1770324) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_058216.3 missense
Scores
Clinical Significance
Conservation
Publications
- RAD51C-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- breast-ovarian cancer, familial, susceptibility to, 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Fanconi anemia complementation group OInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
- hereditary breast ovarian cancer syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 0 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| B2Does not fit gene mode of action | Activating variant in tumor suppressor gene + same AA change classified germline Benign/Likely Benign — supporting benign evidence (B2, no cancer-type context); Activating variant in tumor suppressor gene + same AA change classified germline Benign/Likely Benign — supporting benign evidence (B2, no cancer-type context) | ||
| B3Computational evidence does not support deleterious effect | Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3 |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_058216.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
RAD51C | MANE Select | c.135G>T p.Glu45Asp | missense | Exon 1 of 9 | Prot: NP_478123.1 UniProt: | |
RAD51C | c.135G>T p.Glu45Asp | missense | Exon 1 of 2 | Prot: NP_002867.1 UniProt: | ||
RAD51C | n.177G>T | non_coding_transcript_exon | Exon 1 of 8 | Prot: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
RAD51C | TSL:1MANE Select | c.135G>T p.Glu45Asp | missense | Exon 1 of 9 | Prot: ENSP00000336701.4 UniProt: | |
RAD51C | TSL:1 | c.135G>T p.Glu45Asp | missense | Exon 1 of 2 | Prot: ENSP00000391450.2 UniProt: | |
RAD51C | TSL:1 | n.135G>T | non_coding_transcript_exon | Exon 1 of 8 | Prot: ENSP00000433332.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:32 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 16 | |
AlphaMissense | Benign | 0.12 | |
BayesDel_addAF | Benign | -0.25 | T |
BayesDel_noAF | Benign | -0.60 | |
CADD | Benign | 18 | |
DANN | Benign | 0.90 | |
DEOGEN2 | Benign | 0.0083 | T |
Eigen | Benign | -0.70 | |
Eigen_PC | Benign | -0.59 | |
FATHMM_MKL | Benign | 0.75 | D |
FuncVEP CTI | Benign | 0.0058 | |
GPN-Star LLR | N/A | -4.2 | |
GPN-Star score | N/A | 4.2 | |
LIST_S2 | Benign | 0.79 | T |
M_CAP | Benign | 0.0059 | T |
MetaRNN | Benign | 0.12 | T |
MetaSVM | Benign | -1.1 | T |
Mutation Taster | N/A | 90/10 | polymorphism |
MutationAssessor | Benign | 1.4 | L |
PhyloP100 | Benign | 0.65 | |
popEVE | Benign | -3.1 | |
PrimateAI | Uncertain | 0.60 | T |
PromoterAI | N/A | 0.050 | Neutral |
PROVEAN | Benign | -0.84 | N |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Benign | 0.023 | |
Sift | Benign | 0.51 | T |
Sift4G | Benign | 0.40 | T |
Varity_R | N/A | 0.041 | |
VESM-3B | Benign | -5.2 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.030 | |
SpliceAI score (max) | Benign | 0.010 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.